RANI
Rani Therapeutics Holdings Inc
0.799$
+0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -27.7% | +80.0% | +94.4% | +260.0% | +159.4% | -100.0% | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -83.3% | -100.0% | – | – | +16.9% | +0.0% | – | |
| – | – | – | – | – | – | – | -5.8% | +137.2% | +5.2% | +24.8% | +16.5% | +9.3% | +0.2% | +6.5% | -52.5% | +9.3% | +2.8% | +1.6% | +2.7% | – | – | -7.1% | -16.6% | -13.4% | – | – | |
| – | -27.7% | +80.0% | +94.4% | +260.0% | +159.4% | -106.1% | – | – | – | – | – | – | – | – | – | -109.8% | – | – | – | -83.3% | -239.5% | – | – | +5.9% | +10.4% | – | |
| – | -37.0% | -18.3% | +59.6% | +0.3% | +12.3% | +218.1% | -38.0% | +2.3% | +25.5% | -4.5% | +14.1% | -6.5% | +14.1% | +1.2% | -32.2% | -0.3% | -19.4% | +0.9% | +10.3% | -3.5% | -16.2% | -41.5% | +52.4% | +5.1% | -2.8% | – | |
| – | -36.6% | -5.3% | +115.1% | +43.4% | +32.7% | +357.3% | -62.4% | +4.1% | +2.1% | +14.6% | -2.0% | -4.1% | +5.9% | -7.9% | -12.2% | +10.6% | -0.6% | -12.2% | -2.9% | +2.8% | -11.0% | -19.3% | +26.0% | -4.0% | +13.0% | – | |
| – | -36.9% | -14.9% | +75.6% | +15.5% | +21.2% | +284.8% | -51.9% | +3.1% | +15.0% | +3.1% | +7.0% | -5.5% | +10.8% | -2.4% | -24.8% | +2.6% | -9.2% | -5.8% | +35.5% | -23.8% | -13.8% | -30.9% | +37.7% | -1.1% | +6.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -96.8% | +3,100.0% | +28.1% | +129.3% | -10.1% | -34.9% | -99.1% | +1,400.0% | +133.3% | +905.7% | +104.3% | +67.9% | +4.9% | +3.9% | -1.5% | -0.2% | -1.4% | +4.8% | -15.9% | -16.1% | -7.0% | -17.3% | -52.1% | -74.6% | -90.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -45.5% | -16.7% | +140.0% | +258.3% | -97.7% | +3,600.0% | -208.1% | – | +144.4% | -169.5% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.